Membrane PD-L1 expression and soluble PD-L1 plasma levels in idiopathic pulmonary fibrosis—a pilot study

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) has common risk factors with cancer and significant similarities in the pathobiology process, both diseases having poor outcomes. Immune checkpoint PD-L1 has become the target of checkpoint inhibitory therapy that unleashes antitumor T cells and has re...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Thorac Dis
Hlavní autoři: Jovanovic, Dragana, Roksandic Milenkovic, Marina, Kotur Stevuljevic, Jelena, Markovic, Jelena, Ceriman, Vesna, Kontic, Milica, Skodric Trifunovic, Vesna
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2018
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6344764/
https://ncbi.nlm.nih.gov/pubmed/30746211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.11.16
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky